Our Services

Regulatory Writing

Our specialist skills mean we are uniquely placed to understand and manage your pressures and priorities. And no one does that better than our very own in-house regulatory writing team.

We don’t do one size fits all

Our regulatory writing team have experience working in both big pharma and medical writing agencies, including subcontracting and CROs. This breadth of scale means we can adapt to every type of client requirement.

We’re academic aces

Our regulatory writing team all have academic degrees and most have PhDs in a range of disciplines. These include molecular biology, biochemistry, psychology, physiology, pharmacology, pharmacy, nutrition, and research management!

We’re diligent on documents

Need a formal document written fast? Look no further than our regulatory writing team. We have experience writing all kinds of documents including IMPDs, CSPs and amendments, ICFs/IAFs, DSURs, IBs, CSRs, CTD non-clinical and clinical summary documents, RMPs, PIPs/sPSPs, and briefing documents.

Quote Mark
The Alchemy team were extremely professional, efficient, knowledgeable, and dedicated, delivering several high-quality regulatory documents and protocols in a timely manner. Their medical knowledge, experience and attentiveness to our needs were evident in the recommendations and prioritization of data. The comments they had for us during the process, ability to anticipate our needs, and responsiveness, irrespective of the time zone difference, is illustrative of a truly personalized experience.
Robert T Keenan, Chief Medical Officer – Arthrosi Angle Design

Our service areas

  • Clinical Study Protocols (CSPs)
  • Clinical Study Reports (CSRs)
  • Investigator’s Brochures (IBs)
  • Informed Consent Forms (ICFs)
  • Gap Analysis

  • Common Technical Document (CTD) Modules (Module 2.5, 2.7, 5, etc.)
  • New Drug Applications (NDA)
  • Biologic License Applications (BLA)
  • Marketing Authorization Applications (MAA)
  • Investigational New Drug (IND) Applications
  • Investigational Medicinal Product Dossier (IMPD)
  • Briefing Documents for Regulatory Agencies (e.g., FDA, EMA)
  • Risk Management Plans (RMPs)/ Risk Evaluation and Mitigation Strategy (REMS)
  • Summary of Product Characteristics (SmPCs)
  • United States Prescribing Information (USPI)
  • Paediatric Investigation Plan (PIP)/Paediatric Study Plan (PSP)

  • Periodic Safety Update Reports (PSURs)
  • Periodic Benefit-Risk Evaluation Report (PBRER)
  • Development Safety Update Reports (DSURs)
  • Safety Narratives
  • Safety Summary Reports

  • Clinical Investigation Reports (CIRs)
  • Post-Market Surveillance (PMS) Reports
  • Post-Market Clinical Follow-Up (PMCF) Plans & Reports
  • Device Risk Management Documentation

To find out more about a specific service area please get in touch.

Get in Touch

Elevate your healthcare communications today.

Trust us to create clear, concise, and expertly edited documents that meet your objectives and help to evolve tomorrow’s treatment landscape.

Get in Touch